3 completed, 2 terminated, 1 active not recruiting, 1 unknown. 7 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 3, Terminated 2, Active not recruiting 1, Unknown 1 |
| Phase 2 | 2 | Terminated 2 |
Follow etrasimod: new trials by email Literature Review of etrasimod trials Research Report on etrasimod
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Colitis, Ulcerative (4) · Crohn Disease (1) · Dermatitis, Atopic (1) · Eczema (1) · Inflammatory Bowel Diseases (1)
Pfizer (4) · Arena Pharmaceuticals (2) · Everstar Therapeutics Limited (1)
Canada (5) · Czechia (5) · Poland (5) · United States (5) · Argentina (4) · Australia (4) · Austria (4) · Belarus (4) · Belgium (4) · Bulgaria (4) · Chile (4) · Croatia (4) · Denmark (4) · France (4) · Georgia (4)
Arena CT.gov Administrator (2) · Kaichun Wu (1)
PMID 39778975, PMID 42248437, PMID 36871574, PMID 38613425, PMID 38700040, PMID 38877972, PMID 39089519, PMID 39306680, PMID 39326009, PMID 39526078, PMID 39671695, PMID 39878434, PMID 39891572, PMID 40036804, PMID 40184206, PMID 40618942, PMID 40889900, PMID 41655066, PMID 42523912, PMID 42864953, PMID 39575597, PMID 41043449, PMID 42542725, PMID 42848715
2018 (2)